Skip to Content

TEVA 7335 (Topiramate (sprinkle) 15 mg)

This pill with imprint "TEVA 7335" is White, Capsule-shape and has been identified as Topiramate (sprinkle) 15 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; bipolar disorder; lennox-gastaut syndrome (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate (sprinkle) 15 mg TEVA 7335
Topiramate (sprinkle) 15 mg TEVA 7335
Topiramate (sprinkle) 15 mg TEVA 7335

Topiramate (sprinkle)

Imprint:
TEVA 7335
Strength:
15 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide